key: cord-0875719-3tc0vop1
authors: Merhy, R.; Sarkis, A.S; Stephan, F.
title: Pityriasis rosea as a leading manifestation of COVID‐19 infection
date: 2020-11-30
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.17052
sha: 330bb4df755877de0945db8c44dd79011677eb72
doc_id: 875719
cord_uid: 3tc0vop1

To the Editor: Reported cutaneous manifestations incidence during COVID‐19 infection varied between countries, a recent review showed a worldwide mean incidence of 1.7%. These manifestations are polymorphic, and vary dependently on the disease severity. Few pityriasis rosea (PR) and PR‐like eruptions have been reported during COVID‐19 infection.

A 26year-old woman with no previous medical history, presented to our dermatology clinic for 1

week history of erythematous scaly annular and oval papules over the trunk in a "Christmas tree" like pattern (Fig. 1a) . The eruption was preceded with a herald annular plaque with a peripheral scaling collaret on her right thigh (Fig. 1b) . The patient developed fever, cough and myalgia 48 hours later. She underwent a PCR test for COVID-19, which came back positive.

In this case, PR may be directly linked to COVID-19 infection, or to viral reactivation (e.g.

HHV6, HHV7 and EBV) as previously reported 5 .

To our knowledge, reports on cutaneous manifestations that precede respiratory symptoms in COVID 19 are scarce. Dermatologists should be aware that cutaneous manifestations can be the presenting complaint of COVID-19 patients. 

Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature

The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries

Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19

Acknowledgment: The patient in this manuscript has given written informed consent to publication of her case details